By Dr. Ajit Kumar, MD (Medicine), MA (Psychology) — Founder, Medimadad. About the Author | Editorial Policy
Over the past two years, I’ve had more consultations start with “I’ve been reading about Ozempic” than with any other single topic — and for good reason. GLP-1 receptor agonists have genuinely changed what’s possible in weight and metabolic management, and the pace of new research on them has been unlike anything I’ve seen for a single drug class in my career. This guide exists because I kept having the same conversations with patients one at a time, and it seemed more useful to write down the actual, current, India-relevant picture in one place.
This isn’t a sales pitch for these drugs, and it isn’t a warning against them either. It’s the version of this conversation I’d have with a patient sitting across from me, organized so you can find the specific piece you need.
What GLP-1 drugs actually are, in plain terms
GLP-1 (glucagon-like peptide-1) is a hormone your gut already makes after eating — it slows stomach emptying, tells your brain you’re full, and helps regulate insulin. The drugs in this class (semaglutide — sold as Ozempic and Wegovy; tirzepatide — sold as Mounjaro and Zepbound) are engineered versions that stay active in the body far longer than your natural hormone does, which is why a weekly injection works at all. Newer entrants like survodutide add additional hormone targets (glucagon receptors) on top of the same basic mechanism.
What that means practically: these are not appetite suppressants in the old sense (stimulant-based, working on adrenaline pathways). They work with a system your body already has, which is part of why the side-effect profile — while real — is different from older weight-loss drugs.
Where to start, if you’re new to this
- Tirzepatide vs Semaglutide: Which Weight Loss Drug Is Right for You? — the practical comparison I give patients deciding between the two most established options.
- Ozempic Now Comes in a Pill and The Ozempic Pill Is Finally Here — if needles are the barrier for you, this matters.
- Natural GLP-1 Boosters — for patients who want to understand what’s achievable through diet and lifestyle before or alongside medication.
Safety and special populations — the questions I get asked most
This is where I think the internet conversation about these drugs is weakest — most coverage treats “is it safe” as a yes/no question, when the honest clinical answer is almost always “it depends who you are.”
- Is Ozempic Safe for People with Kidney Disease?
- What Does Ozempic Do to Your Heart? The SELECT Trial Explained
- GLP-1 Drugs and Fertility
- Can Ozempic Help with PCOS?
- Ozempic and Alcohol
- Ozempic and Hair Loss
- Mounjaro vs Ozempic: Which One Destroys More Muscle?
- Can Exercise Replace Ozempic?
Living with the medication: plateaus, discontinuation, and what happens next
The question I probably field most often isn’t “should I start” — it’s “why did it stop working” or “what happens if I stop.” These are under-covered relative to how common they are in practice.
- Scientists Discover Why Ozempic Weight Loss Stops — And How to Overcome the Plateau
- What Happens to Your Body When You Stop Taking Ozempic
- The Forgotten Hormone That Could Make Ozempic Twice as Powerful
- Fibermaxxing: Triggering Your Body’s Own Ozempic Hormone
Beyond weight loss: what the newer research is actually showing
This is the area that’s genuinely moved fastest, and I think it’s under-discussed in mainstream coverage relative to its importance: these drugs appear to do meaningfully more than manage weight.
- Ozempic and Wegovy Are Surprising Doctors: Benefits Beyond Weight Loss
- Ozempic Cuts Depression Risk by 44%
- Ozempic Cuts Breast Cancer Risk by 30%
What’s coming next
The GLP-1 field is not standing still, and I think it’s worth understanding the pipeline even if you’re not a candidate for any of these yet.
- Survodutide: The New Weight Loss Drug That Could Beat Ozempic and Zepbound
- Beyond Ozempic: A New Weight Loss Pill That Burns Fat Without Stealing Muscle
- What Is GIP and Why Does Mounjaro Target It Too?
- Weight Loss Surgery Is Down 25%: Why GLP-1 Drugs Are Taking Over
A note specific to India
Cost and access remain the real barrier for most patients I see, not clinical suitability. Semaglutide and tirzepatide are both available in India through registered pharmacies, but pricing varies significantly by brand and city, and neither is currently subsidized. I’d rather a patient spend time understanding whether they’re a good candidate — metabolic profile, kidney function, personal and family history of thyroid disease or pancreatitis — before spending money working out where to source the drug. If cost is the barrier, several of the natural and lifestyle-based approaches linked above are worth trying first, not as a substitute for medication where it’s genuinely indicated, but because they’re free and often help regardless of what else you do.
Nothing here is a substitute for an actual conversation with your own doctor about your own health. GLP-1 drugs are prescription medications with real contraindications — personal or family history of medullary thyroid cancer or MEN2 syndrome rules them out entirely, and several of the safety questions above (kidney function, cardiovascular history, pregnancy planning) need individual assessment, not a general answer from an article. Use this guide to ask better questions, not to skip the appointment.
This guide is updated as new GLP-1 research is published. Last substantial review: July 2026.
